Depletion of myofibroblasts in mouse pancreas cancer led to invasive tumors
Decreases in fibrosis and myofibroblasts led to enhanced EMT and cancer stem cells
Fewer myofibroblasts in tumors are associated with poor survival in mice and patients
Immunotherapy combined with loss of myofibroblasts prolongs survival